Table 1a.
Dietary regime |
1 |
2 |
3 |
4 |
5 |
p | ᵡ2 | df |
---|---|---|---|---|---|---|---|---|
n | 22 | 25 | 30 | 25 | 6 | |||
Age [years]: median (range) | 2.5 (1–9) | 4.0 (1–9) | 5.0 (1–9) | 4.0 (1–9) | 4.0 (2–9) | 0.399 | 4.052 | 4 |
Age [years]: mean (SD) | 3.7 (2.9) | 4.4 (2.8) | 5.1 (2.9) | 4.5 (2.3) | 4.8(3.1) | |||
Therapeutic range [μmol/l] | 42–240 | 42–240 | 42–240 | 42–240 | 42–240 | |||
Median Phe-concentration [μmol/l] | 161 | 229 | 236 | 249 | 288 | 0.175 | 6.340 | 4 |
Median Phe-concentration [μmol/l]: range | 77–829 | 92–544 | 75–744 | 78–531 | 156–529 | |||
Median Phe-concentration [μmol/l]: interquartile range(IQR) | 96–285 | 161–327 | 176–299 | 178–292 | 210–503 | |||
Median Phe-concentrations > therapeutic range [%] | 17 | 50 | 42 | 50 | 75 | 0.035a | 10.033 | 4 |
Median Phe-concentrations > therapeutic range [%]: range | 0–100 | 0–100 | 0–100 | 0–100 | 0–100 | |||
Median Phe-concentrations > therapeutic range [%]: IQR | 0–38 | 17–75 | 17–83 | 17–75 | 25–100 | |||
Phe intake [mg]: median (range) | 295 (160–590) | 290 (180–670) | 300 (220–475) | 300 (200–700) | 570 (250–800) | 0.019b | 11.341 | 4 |
Adherence to amino acid mixture: median (range) | 5 (3–5) | 5 (4–5) | 5 (3–5) | 5 (3–5) | 5 (2–5) | 0.119 | 6.800 | 4 |
Burden of dietary regime: median (range) | 3 (1–5) | 3 (2–5) | 3 (3–5) | 3 (1–5) | 3 (2–4) | 0.070 | 8.238 | 4 |
Dietary regime 1 vs 2: p = 0.022; 1 vs 3: p = 0.007; 1 vs 4: p = 0.028; 1 vs 5: p = 0.033 (post hoc analyses: Mann–Whitney U)
Dietary regime 1 vs 5: p = 0.008; 2 vs 5: p = 0.007; 3 vs 5: p = 0.008; 4 vs 5: p = 0.006 (post hoc analyses: Mann–Whitney U)